Evidence map›Paper›PMID 28539628›Full record

ArticleScientific reports2017

Low level of Lck kinase in Th2 cells limits expression of CD4 co-receptor and S73 phosphorylation of transcription factor c-Jun.

Yury V Shebzukhov, Silke Stanislawiak, Taisiya R Bezhaeva, Sergei A Nedospasov, Dmitry V Kuprash

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yury V ShebzukhovGerman Rheumatism Research Center, a Leibniz Institute, Berlin, Germany. yshebzuk@yahoo.com.
Silke StanislawiakGerman Rheumatism Research Center, a Leibniz Institute, Berlin, Germany.
Taisiya R BezhaevaGerman Rheumatism Research Center, a Leibniz Institute, Berlin, Germany.
Sergei A NedospasovGerman Rheumatism Research Center, a Leibniz Institute, Berlin, Germany.
Dmitry V KuprashEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
German Rheumatism Research Centre · DEEngelhardt Institute of Molecular Biology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Src-family tyrosine kinase Lck is an enzyme associated with the CD4 and CD8 co-receptors and promoting signaling through the T cell receptor (TCR) complex. The levels of Lck expression and activity change during the development and differentiation of T cells. Here we show that Lck expression is higher in Th1 cells as compared to Th2 cells. Ectopic overexpression of Lck in Th2 cells results in increased expression of CD4 co-receptor and enhanced S73 phosphorylation of transcription factor c-Jun. Our findings indicate that TCR-mediated signaling in Th2 cells may be directly attenuated by Lck protein expression level.

Indexed as

AnimalsCD4-Positive T-LymphocytesCells, CulturedGene Expression ProfilingHEK293 CellsHumansLymphocyte Specific Protein Tyrosine Kinase p56(lck)Mice, Inbred C57BLPhosphorylationProto-Oncogene Proteins c-junReceptors, Antigen, T-CellSerineSignal TransductionTh1 CellsTh2 CellsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Proto-Oncogene Proteins c-junReceptors, Antigen, T-CellSerine

Identifiers

PMID28539628
PMCPMC5443812
OpenAlexW2614291230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.